support_agent

Your contact persons

CHEPLAPHARM Arzneimittel GmbH

View:
format_list_bulletedgrid_view

04/28/2023

CHEPLAPHARM places notes in a volume of €750m in challenging market environment
Press releases
Read morechevron_right

04/26/2023

Announcement on Pricing
Press releases
Read morechevron_right

04/24/2023

Announcement on Offering
Press releases
Read morechevron_right

04/22/2023

CHEPLAPHARM announces acquisition of Zyprexa® from Lilly
Press releases
Read morechevron_right

03/01/2023

CHEPLAPHARM strengthens portfolio with asthma treatment from AstraZeneca
Press releases
Read morechevron_right

01/23/2023

CHEPLAPHARM continues expansion in China with the acquisition of XELODA® from Roche
Press releases
Read morechevron_right

12/01/2022

Change in the Management of CHEPLAPHARM
Press releases
Read morechevron_right

11/29/2022

CHEPLAPHARM remains on growth track
Press releases
Read morechevron_right

10/25/2022

CHEPLAPHARM receives growth capital of €550 Million from two leading global investors
Press releases
Read morechevron_right

08/29/2022

CHEPLAPHARM increases revenue and earnings in the first half of 2022
Press releases
Read morechevron_right
Back to topexpand_less